Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
Lisata Therapeutics to Participate in Upcoming April 2024 Industry and Investor Events
BASKING RIDGE, N.J., April 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that David J. Mazzo, PhD, President and Chief Executive Officer of Lisata, will participate in the following events in April:
新泽西州巴斯金里奇，2024年4月3日（环球新闻专线）——开发治疗晚期实体瘤和其他严重疾病创新疗法的临床阶段制药公司Lisata Therapeutics, Inc.（纳斯达克股票代码：LISATA）（“Lisata” 或 “公司”）今天宣布，Lisata总裁兼首席执行官戴维·马佐博士将在4月参加以下活动：
LD Micro Invitational XIV (April 8-9, 2024)
Format: In-person and On-demand
Location: Sofitel New York Hotel in New York City
Presentation Date: Tuesday, April 9, 2024
Presentation Time: 10:00 a.m. Eastern Time
Presentation Track: Track 4 – Montmartre
LD 微型邀请赛 XIV（2024 年 4 月 8 日至 9 日）
格式：面对面和点播
地点：纽约市的索菲特纽约酒店
演讲日期：2024 年 4 月 9 日星期二
演讲时间：美国东部时间上午 10:00
演示曲目：曲目 4 — 蒙马特
Register for Webcast: https://ldinv14.sequireevents.com/
注册观看网络直播： https://ldinv14.sequireevents.com/
Management will be available for one-on-one meetings with registered investors of the conference. Please reach out to the Lisata representative under the contact section below or Dean Summers at LD Micro (dean@ldmicro.com) to register for the event and schedule a meeting with the Company.
管理层将可以与会议的注册投资者进行一对一的会面。请通过以下联系部分联系Lisata代表或LD Micro的迪恩·萨默斯（dean@ldmicro.com) 注册参加活动并安排与公司的会议。
FORCE Family Office Webinar with Lisata Therapeutics (April 10, 2024)
Format: Webinar - Virtual
Webinar Date: Wednesday, April 10, 2024
Webinar Time: 12:00 p.m. Eastern Time / 9:00 a.m. Pacific Time
与Lisata Therapeutics合作的FORCE家族办公室网络研讨会（2024年4月10日）
形式：网络研讨会-虚拟
网络研讨会日期：2024 年 4 月 10 日星期三
网络研讨会时间：东部时间下午 12:00 /太平洋时间上午 9:00
Webinar details will be provided upon RSVP approval. To register for the event, please visit www.forcefamilyoffice.com/events/healthcare/lisata-therapeutics-coming-april-10-2024
网络研讨会的详细信息将在RSVP批准后提供。要注册参加此次活动，请访问 www.forcefamilyoffice.com/events/healthcare/lisata-therapeics-coming-2024 年 4 月
Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference (April 17-18, 2024)
Format: Virtual
Presentation Date: Wednesday, April 17, 2024
Presentation Time: 1:30 p.m. Eastern Time
诺布尔资本市场新兴增长虚拟医疗股票会议（2024年4月17日至18日）
格式：虚拟
演讲日期：2024 年 4 月 17 日，星期三
演讲时间：美国东部时间下午 1:30
Management will be available for one-on-one meetings with registered investors of the conference. Please reach out to the Lisata representative under the contact section below or events@noblecapitalmarkets.com to register for the event and schedule a meeting with the Company. For more information on the event, please visit https://bit.ly/3VwVxbz.
管理层将可以与会议的注册投资者进行一对一的会面。请在下面的联系部分下与 Lisata 代表联系，或 events@noblecapitalmarkets.com 注册参加活动并安排与公司的会面。有关该活动的更多信息，请访问 https://bit.ly/3VwVxbz。
Immuno-Oncology Summit Europe (April 23-25, 2024)
Format: In-person and On-demand
Location: Hilton London Canary Wharf in London, UK
Presentation Date: Tuesday, April 23, 2024
Presentation Time: 4:30 p.m. British Summer Time / 11:30 a.m. Eastern Time
Conference Program: Modulating the Tumour Microenvironment
欧洲免疫肿瘤学峰会（2024 年 4 月 23-25 日）
格式：面对面和点播
地点：英国伦敦金丝雀码头希尔顿酒店
演讲日期：2024 年 4 月 23 日，星期二
演讲时间：英国夏令时间下午 4:30 /东部时间上午 11:30
会议日程：调节肿瘤微环境
To register for the event, please visit www.immuno-oncologyeurope.com.
要注册参加此次活动，请访问 www.immuno-oncologyeurope.com。
About Lisata Therapeutics
关于 Lisata Therapeu
Lisata Therapeutics is a clinical-stage pharmaceutical company dedicated to the discovery, development and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Lisata's lead product candidate, LSTA1, is an investigational drug designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate solid tumors more effectively. Based on Lisata's CendR Platform Technology, Lisata has already established noteworthy commercial and R&D partnerships. The Company expects to announce numerous clinical study and business milestones over the next two years and has projected that its current business and development plan is funded with available capital through these milestones and into early 2026. For more information on the Company, please visit www.lisata.com.
Lisata Therapeutics 是 处于临床阶段的制药公司 致力于发现、开发和商业化治疗晚期实体瘤和其他主要疾病的创新疗法。Lisata的主要候选产品， LSTA1，是一种在研药物，旨在激活一种新的摄取途径，使共同使用或联用的抗癌药物能够更有效地靶向和穿透实体瘤。基于 Lisata 的 cENDR 平台 科技，Lisata已经建立了值得注意的商业和研发合作伙伴关系。该公司预计将在未来两年内宣布许多临床研究和业务里程碑，并预计其当前的业务和发展计划将通过这些里程碑到2026年初的可用资本提供资金。有关该公司的更多信息，请访问 www.lisata.com。
Contact:
联系人：
Investors and Media:
投资者和媒体：
Lisata Therapeutics, Inc.
John Menditto
Vice President, Investor Relations and Corporate Communications
Phone: 908-842-0084
Email: jmenditto@lisata.com
Lisata Therapeutics, In
约翰·门迪托
投资者关系和企业传播副总裁
电话：908-842-0084
电子邮件： jmenditto@lisata.com
译文内容由第三方软件翻译。